Timothy Ramos
Nurse Practitioner · Brandon, FLNPI 1851884944
Payments from drug & device makers
Across 262 payments — averaging $25.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Viiv Healthcare Company$1K
- Gilead$864
- AbbVie$811
- Melinta Therapeutics, LLC$754
- Paratek Pharmaceuticals, Inc.$606
- Merck$589
- plus $2K from 20 others
What the payments were for
- Food & beverage$6,48097%
- Education$2003%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Viiv Healthcare Company | 45 | $1,028 |
| Gilead | 36 | $864 |
| AbbVie | 33 | $811 |
| Melinta Therapeutics, LLC | 23 | $754 |
| Paratek Pharmaceuticals, Inc. | 26 | $606 |
| Merck | 29 | $589 |
| Insmed, Inc. | 19 | $493 |
| Astellas Pharma US Inc | 6 | $267 |
| Ferring Pharmaceuticals Inc. | 5 | $244 |
| La Jolla Pharmaceutical Company | 6 | $194 |
| Abbott | 1 | $160 |
| Aimmune Therapeutics, Inc. | 7 | $150 |
| Shionogi Inc | 7 | $135 |
| Theratechnologies Inc. | 4 | $90 |
| Johnson & Johnson | 3 | $60 |
| Tetraphase Pharmaceuticals, Inc. | 1 | $30 |
| Redhill Biopharma Inc. | 1 | $27 |
| Tersera Therapeutics LLC | 1 | $26 |
| GSK | 1 | $22 |
| Smith+Nephew | 1 | $22 |
| Boston Scientific | 1 | $21 |
| Grifols USA, LLC | 1 | $20 |
| Electromed, Inc. | 1 | $17 |
| Nalu Medical, Inc. | 2 | $17 |
| Pharmacosmos Therapeutics Inc. | 1 | $16 |
| Vertos Medical, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REBYOTA$163
- Proclaim IPG$160
- NUZYRA$124
- Rezzayo$109
How this compares
$6,680 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 156 | $616,104 |
| ArikayceAmikacin Liposomal/Neb.Accessr | 12 | $186,649 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 18 | $162,241 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 28 | $97,622 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 19 | $78,985 |
| StribildElviteg/Cob/Emtri/Tenofo Disop | 18 | $76,859 |
| PrezcobixDarunavir/Cobicistat | 22 | $60,941 |
| TriumeqAbacavir/Dolutegravir/Lamivudi | 13 | $47,261 |
| Daptomycin | 36 | $46,360 |
| IsentressRaltegravir Potassium | 22 | $44,724 |
| DovatoDolutegravir Sodium/Lamivudine | 11 | $30,621 |
| TivicayDolutegravir Sodium | 12 | $27,065 |
| Etravirine | 20 | $21,882 |
| AptivusTipranavir | 12 | $21,588 |
| Abacavir-LamivudineAbacavir Sulfate/Lamivudine | 14 | $7,603 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Genvoya, Stribild | $864 | $771,948193 claims |
| Insmed, Inc.Arikayce | $493 | $186,64912 claims |
| Grifols USA, LLCGamunex-C | $20 | $162,24118 claims |
| Viiv Healthcare CompanyTriumeq, Dovato, Tivicay | $1,028 | $104,94736 claims |
| Johnson & JohnsonPrezcobix | $60 | $60,94122 claims |
| MerckIsentress | $589 | $44,72422 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,290 nurse practitioner providers in Florida.
Other nurse practitioner in Brandon
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.